These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8609280)

  • 21. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
    Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
    J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group.
    Highton A; Quell J
    J Am Acad Dermatol; 1995 Jan; 32(1):67-72. PubMed ID: 7822519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination phototherapy of psoriasis with calcipotriene and narrow-band (311 nm) UVB.
    Lehmann P; Kerscher M
    J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):501-2. PubMed ID: 9091500
    [No Abstract]   [Full Text] [Related]  

  • 28. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
    Lebwohl M; Yoles A; Lombardi K; Lou W
    J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the safety of calcipotriene 30 g per day in patients with psoriasis: a parallel group, vehicle-controlled study.
    Blum R; Schwartzel E; Siskin S; Epinette WW
    J Clin Pharmacol; 1998 Apr; 38(4):368-72. PubMed ID: 9590465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
    White S; Vender R; Thaçi D; Haverkamp C; Naeyaert JM; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
    Am J Clin Dermatol; 2006; 7(3):177-84. PubMed ID: 16734505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB.
    Fetil E; Ilknur T; Altiner D; Ozkan S; Güneş AT
    J Dermatol; 2005 Nov; 32(11):868-74. PubMed ID: 16361746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcipotriol ointment under occlusion gives a fast onset of action.
    Hindsén M; Traulsen J
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):764-5. PubMed ID: 16836527
    [No Abstract]   [Full Text] [Related]  

  • 37. Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.
    Koo J; Tyring S; Werschler WP; Bruce S; Olesen M; Villumsen J; Bagel J
    J Dermatolog Treat; 2016; 27(2):120-7. PubMed ID: 26444907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical calcipotriene ointment and etretinate: another combination therapy for psoriasis vulgaris.
    Vázquez-López F; Pérez-Oliva N; Hernandez-Mejia R
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):803. PubMed ID: 9146555
    [No Abstract]   [Full Text] [Related]  

  • 39. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical vitamin D analogs.
    Kieffer MA
    Dermatol Nurs; 2004 Feb; 16(1):89-90, 93, 100. PubMed ID: 15022510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.